Black patients more likely to be excluded from pancreatic cancer clinical trials

4.6 (137) · $ 23.00 · In stock

The Targeted Pulse: New Pancreatic Cancer Therapy, Shifts in Lung

Biden's FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B - The Cancer Letter

Frontiers Mechanisms Governing Immunotherapy Resistance in

Black patients more likely to be excluded from pancreatic

Washington University SPORE in Pancreatic Cancer

Cureus WT1 Cancer Vaccine in Advanced Pancreatic Cancer: A

Issue 13 - The Cancer Letter

Association between intraoperative intravenous lidocaine infusion

Black patients more likely to be excluded from pancreatic cancer

Pancreatic Cancer and the Black Community - Pancreatic Cancer

Black patients more likely to be excluded from pancreatic cancer clinical trials - Augusta Free Press

Uncovering the clinicopathological features of early recurrence

Flowchart of the Norwegian pancreatic cancer trial-1

Racial Disparities in Cancer Outcomes, Screening, and Treatment

SOM Discoveries 2022 VCU School of Medicine